Amphastar Pharmaceuticals AMPH
NASDAQ AMPH
$29.38 +0.89 (+3.12%)
At close: Nov 9, 2026 · 4:00 PM EST

Amphastar Pharmaceuticals (AMPH) Non Operating Interest Expenses (2013 - 2026)

Updated

Amphastar Pharmaceuticals (AMPH) posted Non Operating Interest Expenses of $6.66 million for Q2 2026, up 6.0% from $6.28 million a year earlier and up 1.6% from the prior quarter.

Analysis

Amphastar Pharmaceuticals (AMPH) Non Operating Interest Expenses (2013 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Non Operating Interest Expenses at Amphastar Pharmaceuticals was $26.13 million, up 1.7% year-over-year; for FY2025, it was $25.48 million, down 16.0% from FY2024.

  • Annual Non Operating Interest Expenses shows a five-year compound annual growth rate of 132.6% (FY2020 to FY2025).
  • In prior years, Amphastar Pharmaceuticals' Non Operating Interest Expenses was $30.34 million in FY2024 (+11.7%), $27.16 million in FY2023, $1.85 million in FY2022 (+108.6%) and $885,000 in FY2021 (+136.6%).
  • The Q2 2026 figure stands as the highest quarterly Non Operating Interest Expenses since Q3 2024.
  • On a year-over-year basis, Non Operating Interest Expenses has increased in each of the last three quarters, with an average decline of 16.2% over the last eight quarters.
  • The strongest year-over-year quarter for Non Operating Interest Expenses in the past five years was Q2 2023, with growth of 807.3%; the weakest was Q3 2024, with a decline of 51.1%.
  • According to Business Quant data, Non Operating Interest Expenses for the three prior quarters was $6.55 million (Q1 2026), $6.63 million (Q4 2025) and $6.28 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn -
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 217.00 Mn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn -
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn -
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn -477.00 Mn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 653.00 Mn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn 269.00 Mn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn -
10 Amphastar Pharmaceuticals 1.25 Bn 156.30 Mn 99.63 Mn 6.76 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 6.76 Mn
Jun 30, 2026 6.66 Mn
Mar 31, 2026 6.55 Mn
Dec 31, 2025 6.63 Mn
Sep 30, 2025 6.28 Mn
Jun 30, 2025 6.28 Mn
Mar 31, 2025 6.29 Mn
Dec 31, 2024 6.43 Mn
Sep 30, 2024 6.70 Mn
Jun 30, 2024 8.61 Mn
Mar 31, 2024 8.61 Mn
Dec 31, 2023 9.46 Mn
Sep 30, 2023 13.70 Mn
Jun 30, 2023 3.60 Mn
Mar 31, 2023 398,000.00
Dec 31, 2022 528,000.00
Sep 30, 2022 566,000.00
Jun 30, 2022 397,000.00
Mar 31, 2022 355,000.00
Dec 31, 2021 168,000.00
API Access

Amphastar Pharmaceuticals Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=AMPH&period=max&api_key=YOUR_API_KEY